HESI/FDA workshop on immunomodulators and cancer risk assessment: Building blocks for a weight-of-evidence approach

H. Lebrec, F. R. Brennan, H. Haggerty, D. Herzyk, C. Kamperschroer, C. C. Maier, R. Ponce, B. D. Preston, D. Weinstock, R. D. Mellon

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'HESI/FDA workshop on immunomodulators and cancer risk assessment: Building blocks for a weight-of-evidence approach'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds